Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Hologic, Inc.    HOLX   US4364401012

HOLOGIC, INC. (HOLX)

9
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Hologic, Inc. : Hologic to Present at Three Upcoming Investor Conferences

05/09/2013 | 07:05am US/Eastern
Recommend:
0

BEDFORD, Mass., May 9, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that company management will participate in the following investor conferences:

    --  Glenn Muir, Executive Vice President and Chief Financial Officer, will
        present at:
        --  The Bank of America Merrill Lynch 2013 Health Care Conference in Las
            Vegas, Nevada on Tuesday, May 14, 2013 at 11:40 a.m. Eastern Time
            (ET).
        --  The William Blair 33(rd) Annual Growth Stock Conference in Chicago,
            Illinois on Wednesday, June 12, 2013 at 1:40 p.m. ET.
    --  Rob Cascella, President and Chief Executive Officer, will present at:
        --  The Goldman Sachs 34(th) Annual Global Healthcare Conference in
            Rancho Palos Verdes, California on Wednesday, June 12, 2013 at 2:20
            p.m. ET.

Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.

About Hologic, Inc.:

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.


    Contacts:


    Deborah R. Gordon                  Al Kildani

    Vice President, Investor Relations Senior Director, Investor Relations

    (781) 999-7716                     (858) 410-8653

    deborah.gordon@hologic.com         al.kildani@hologic.com

SOURCE Hologic, Inc.

Recommend :
0
React to this article
Latest news on HOLOGIC, INC.
1d ago HOLOGIC : Assigned Patent
2d ago HOLOGIC : Researchers Submit Patent Application, "Cervical Sealing Apparatus", f..
2d ago ROKA BIOSCIENCE : Hologic Announces Third Quarter Fiscal 2014 Operating Results
2d ago HOLOGIC : Management's Discussion and Analysis of Financial Condition and Result..
3d ago HOLOGIC : Results of Operations and Financial Condition, Financial Statements an..
3d ago HOLOGIC : Announces Third Quarter Fiscal 2014 Operating Results
5d ago HOLOGIC : GRIFOLS -New highly sensitive test to screen donors of blood, tissues,..
07/25 HOLOGIC : Assigned Patent
07/24 HOLOGIC : Researchers Submit Patent Application, "Swab Assembly for Specimen Col..
07/23 HOLOGIC : Special Notice - J-- Service of Hologic Mammogram Unit
Dynamic quotes  
ON
| OFF